Sarmoxicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H27N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R15K9Z4384, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(4-(4-hydroxyphenyl)-2,2-dimethyl-5-oxo-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, methoxymethyl ester, (2s-(2alpha,5alpha,6beta))- but generally known as sarmoxicillin, which bears US NIH Compound Identifier 49808. European Medicines Agency schedules Sarmoxicillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10453MIG. The term SARMOXICILLIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). SARMOXICILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sarmoxicillin under HS 29411090 and SITC 54131. As of Q4 2014, SARMOXICILLIN remains the US FDA Preferred Term for this commodity. Sarmoxicillin bears US NLM identifiers UMLS ID C0614192 and NCI Concept Code C82302. SMILES: S1C2N(C(C1(C)C)C(=O)OCOC)C(=O)C2N1C(NC(C1=O)C1CCC(O)CC1)(C)C.